Literature DB >> 9881820

Autism and Clostridium tetani.

E R Bolte.   

Abstract

Autism is a severe developmental disability believed to have multiple etiologies. This paper outlines the possibility of a subacute, chronic tetanus infection of the intestinal tract as the underlying cause for symptoms of autism observed in some individuals. A significant percentage of individuals with autism have a history of extensive antibiotic use. Oral antibiotics significantly disrupt protective intestinal microbiota, creating a favorable environment for colonization by opportunistic pathogens. Clostridium tetani is an ubiquitous anaerobic bacillus that produces a potent neurotoxin. Intestinal colonization by C. tetani, and subsequent neurotoxin release, have been demonstrated in laboratory animals which were fed vegetative cells. The vagus nerve is capable of transporting tetanus neurotoxin (TeNT) and provides a route of ascent from the intestinal tract to the CNS. This route bypasses TeNT's normal preferential binding sites in the spinal cord, and therefore the symptoms of a typical tetanus infection are not evident. Once in the brain, TeNT disrupts the release of neurotransmitters by the proteolytic cleavage of synaptobrevin, a synaptic vesicle membrane protein. This inhibition of neurotransmitter release would explain a wide variety of behavioral deficits apparent in autism. Lab animals injected in the brain with TeNT have exhibited many of these behaviors. Some children with autism have also shown a significant reduction in stereotyped behaviors when treated with antimicrobials effective against intestinal clostridia. When viewed as sequelae to a subacute, chronic tetanus infection, many of the puzzling abnormalities of autism have a logical basis. A review of atypical tetanus cases, and strategies to test the validity of this paper's hypothesis, are included.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881820     DOI: 10.1016/s0306-9877(98)90107-4

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  47 in total

Review 1.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik; Elena F Verdu
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

Review 3.  Gut microbiota in autism and mood disorders.

Authors:  Francesca Mangiola; Gianluca Ianiro; Francesco Franceschi; Stefano Fagiuoli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Brief Report: Association Between Autism Spectrum Disorder, Gastrointestinal Problems and Perinatal Risk Factors Within Sibling Pairs.

Authors:  Johan Isaksson; Erik Pettersson; Elzbieta Kostrzewa; Rochellys Diaz Heijtz; Sven Bölte
Journal:  J Autism Dev Disord       Date:  2017-08

Review 5.  Gut Microbiota and Autism: Key Concepts and Findings.

Authors:  Helen T Ding; Ying Taur; John T Walkup
Journal:  J Autism Dev Disord       Date:  2017-02

Review 6.  New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.

Authors:  Rachna Patel; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

7.  More Than a Gut Feeling: The Implications of the Gut Microbiota in Psychiatry.

Authors:  Pochu Ho; David A Ross
Journal:  Biol Psychiatry       Date:  2017-03-01       Impact factor: 13.382

Review 8.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

Review 9.  Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight.

Authors:  Fares Zeidán-Chuliá; José Luiz Rybarczyk-Filho; Alla B Salmina; Ben-Hur Neves de Oliveira; Mami Noda; José Cláudio F Moreira
Journal:  Neuromolecular Med       Date:  2013-03-02       Impact factor: 3.843

10.  Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.

Authors:  Woo Jung Lee; Lakshmi D N Lattimer; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.